Helospectin I and II evoke vasodilation in the intact peripheral microcirculation.
Helospectin I and II, two closely related mammalian neuropeptides of the secretin/glucagons/vasoactive intestinal peptide (VIP) superfamily of peptides, are co-localized with VIP in nerve fibers surrounding vascular smooth muscle. However, the role if any, VIP receptors play in transducing the vasorelaxant effects of helospectin I and II in the intact peripheral microcirculation is uncertain. The purpose of this study was to determine whether helospectin I and II elicit vasodilation in the intact peripheral microcirculation and, if so, whether this response is mediated, in part, by VIP or pituitary adenylate cyclase activating peptide (PACAP) receptor engagement, and through local elaboration of cyclooxygenase products of arachidonic acid metabolism. Using intravital microscopy, we found that suffusion of helospectin I and II (each, 1.0 nmol) evoked potent vasodilation and of similar magnitude in the intact hamster cheek pouch microcirculation (P < 0.05). Suffusion of 0.1 nmol helospectin I and II had no significant effects on arteriolar diameter. Pretreatment with VIP(10-28), a VPAC1/VPAC2 receptor antagonist, or PACAP(6-38), a PAC1/VPAC2 receptor antagonist, had no significant effects on helospectin I- and II-induced responses. In addition, pretreatment with indomethacin had no significant effects on helospectin I- and II-induced vasodilation. Collectively, these data indicate that helospectin I and II evoke potent vasodilation in the intact peripheral microcirculation that is not transduced by VIP or PACAP receptors nor through cyclooxygenase products of arachidonic acid metabolism.
Tsueshita
Takaya
T
Department of Medicine (M/C 719), University of Illinois at Chicago, 840 South Wood Street, Room 173, Chicago, IL 60612-7323, USA.
Onyükusel
Hayat
H
Sethi
Varun
V
Gandhi
Salil
S
Rubinstein
Israel
I
D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism; D002610:Cheek / Q000098:blood supply / Q000294:innervation; D006224:Cricetinae; D036341:Intercellular Signaling Peptides and Proteins; D008833:Microcirculation / Q000294:innervation; D009479:Neuropeptides / Q000378:metabolism / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism / Q000494:pharmacology; D014664:Vasodilation / Q000187:drug effects*
D036341:Intercellular Signaling Peptides and Proteins; D009479:Neuropeptides; D010455:Peptides; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D016718:Arachidonic Acid; D014660:Vasoactive Intestinal Peptide; C043046:helospectin I; C043047:helospectin II